Document is current

Article History

Received: 10 December 2024

Accepted: 28 January 2025

First Online: 10 February 2025

Declarations

:

: Tiago Torres has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Amgen, Almirall, Amgen, Apogee Therapeutics, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius-Kabi, Johnson & Johnson Innovative Medicine, LEO Pharma, Eli Lilly, MSD, Mylan, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme, Sandoz, STADA and UCB. Tiago Torres is also an Editorial Board member of Dermatology and Therapy. Tiago Torres was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Pedro Mendes-Bastos has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by Lilly, AbbVie, Janssen, Novartis, LEO Pharma, Almirall, Sanofi, Regeneron, Viatris, Pierre Fabre, L’Oréal, Organon, Evelo Biosciences, CS Portugal, Pfizer, Biogen, Apogee, Amgen. Margarida Gonçalo has participated in clinical trials, advisory board and/or lectures promoted by Abbvie, Almirall, Amgen, AstraZeneca, Biogen, Eli Lilly, Janssen, Leo Pharma, Novartis, Pfizer, Sanofi-Genzyme, Takeda. Maria João Cruz has participated in clinical trials, advisory board and/or lectures promoted by Abbvie, Almirall, Amgen, Janssen, Leo Pharma, Eli Lilly, Novartis, Pfizer and Sanofi-Genzyme. Bruno Duarte has participated in clinical trials, advisory board and/or lectures promoted by Abbvie, Almirall, Janssen, Leo Pharma, Eli Lilly, Pfizer and Sanofi-Genzyme. Maria João Paiva-Lopes has participated in clinical trials, advisory board and/or lectures promoted by AbbVie, Almirall, Boehringer Ingelheim, Janssen, Leo-Pharma, Eli Lilly, Novartis, Pfizer, Sanofi-Genzyme, Viatris. Paulo Filipe has nothing to disclose.

: This study did not involve new studies with human participants or animals.